Position in CDXS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$15,334,100
+$4,274,550 QoQ
Shares Held
6,785,000
0.0% QoQ
Ownership
6.20%
of shares outstanding
% of Portfolio
1.41%
of 13F equity value
Holder Rank
#2
of 148 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CDXS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Opaleye Management Inc. holds $678,840,611 across 50 Biotechnology names. CDXS ranks #16 (2.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IRON |
Disc Medicine, Inc.
|
855,000 | $62,534,700 | |
| 2 | URGN |
UroGen Pharma Ltd.
|
1,439,996 | $52,991,852 | |
| 3 | 390,000 | $51,764,700 | |||
| 4 | MGTX |
MeiraGTx Holdings plc
|
3,550,000 | $47,960,500 | |
| 5 | SLGL |
Sol-Gel Technologies Ltd.
|
500,000 | $37,070,000 | |
| 6 | RZLT |
Rezolute, Inc.
|
6,300,000 | $32,760,000 | |
| 7 | TGTX |
Tg Therapeutics, Inc.
|
535,000 | $29,392,900 | |
| 8 | IMMX |
Immix Biopharma, Inc.
|
2,345,000 | $24,176,950 |
All Filings in CDXS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $15,334,100 | 6,785,000 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $11,059,550 | 6,785,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $11,067,272 | 6,789,738 | Shares | Sole | 2026-04-13 | |
| 2025-09-30 | $31,219,800 | 12,795,000 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $30,744,000 | 12,600,000 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $25,555,000 | 9,500,000 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $42,166,800 | 8,840,000 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $27,011,600 | 8,770,000 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $10,710,500 | 3,455,000 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $10,888,800 | 3,120,000 | Shares | Sole | 2024-05-29 | |
| 2023-12-31 | $9,288,851 | 3,045,525 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $2,114,721 | 1,118,900 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $1,890,000 | 675,000 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $3,105,000 | 750,000 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $4,461,950 | 957,500 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $6,999,300 | 1,155,000 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $13,477,187 | 1,288,450 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $27,733,900 | 1,345,000 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $42,058,150 | 1,345,000 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $31,284,700 | 1,345,000 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $30,477,700 | 1,345,000 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $32,046,000 | 1,400,000 | Shares | Sole | 2021-05-18 | |
| 2020-12-31 | $30,562,000 | 1,400,000 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $16,436,000 | 1,400,000 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $15,960,000 | 1,400,000 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $15,624,000 | 1,400,000 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||